TITLE

Ticagrelor was more effective than clopidogrel, with no increase in major bleeding in acute coronary syndromes

AUTHOR(S)
Bates, Eric R.
PUB. DATE
December 2009
SOURCE
ACP Journal Club;12/15/2009, Vol. 151 Issue 6, p2
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article presents information on a clinical trial which examines the relative efficacy and safety of ticagrelor and clopidogrel in patients with acute coronary syndromes (ACSs). 18,624 patients of 18 years were selected from 862 centers in 43 countries worldwide. The results show that in patients with acute coronary syndromes, ticagrelor helped in preventing major adverse cardiovascular events at 1 year than clopidogrel, with no increase in major bleeding.
ACCESSION #
47420847

 

Related Articles

  • Ticagrelor was more effective than clopidogrel in acute coronary syndromes with planned invasive treatment. Brophy, James M. // ACP Journal Club;5/18/2010, Vol. 152 Issue 5, p3 

    The article reports on a study that discusses safety and efficiency of ticagrelor and clopidogrel in patients with planned invasive management of an acute coronary syndrome (ACS). As stated, based on a secondary analysis of randomized controlled trial, thousands of patients were admitted for an...

  • MedicationUpdate.  // McKnight's Long-Term Care News;Apr2010, Vol. 31 Issue 4, p10 

    The article presents medical news briefs including a safety warning placed by the U.S. Food and Drug Administration on Plavix, the need for medical professionals to exercise care before giving statins to nursing home residents, and a study on adding prednisolone to antibiotics in patients with...

  • CHOLESTEROL-LOWERING DRUGS FOUND TO BE EQUALLY EFFECTIVE IN WHITE, BLACK AND SOUTH ASIAN PATIENTS.  // Ethnicity & Disease;Spring2011, Vol. 21 Issue 2, p256 

    The article presents a study on the effectiveness of the use of statin drugs among White, Black and South Asian patients in reducing cardiovascular disease and death.

  • Polypill to help combat CVD. Newson, Louise // GP: General Practitioner;9/14/2007, p41 

    The article examines the role of polypill in combating cardiovascular diseases in Great Britain. The concept of polypill suggests six ingredients--a statin, aspirin, folic acid and three antihypertensives each at half dose. It discusses several evidences that support polypill's role including...

  • Atorvastatin Delays Cardiovascular Disease in Patients with Diabetes. Barry, Henry // American Family Physician;1/15/2005, Vol. 71 Issue 2, p347 

    Discusses research being done on the effectiveness of atorvastatin in the primary prevention of cardiovascular disease in adults with diabetes mellitus. Reference to a study by H. M. Colhoun et al published in the August 21, 2004 issue of "Lancet"; Number of study participants; Percentage of...

  • LIPANTHYL SUPRA -- SUPRABIODOSTĘPNA POSTAĆ FENOFIBRATU. POSTĘP W TERAPII DYSLIPIDEMII. Poliwczak, Adam Rafał; Chojnowska-Jezierska, Julita // Problemy Terapii Monitorowanej;mar2008, Vol. 19 Issue 1, p75 

    Cardiovascular disease which develops on the basis of atherosclerosis is the main cause of mortality and morbidity in adults and is a huge financial burden. The very beginning of dyslipidemia modern therapy was discovery of fibrates and statins. Fenofibrate is a major representant of the fibrate...

  • Analysis of Efficacy and Safety in Patients Aged 65-75 Years at Randomization. Neil, H. Andrew W.; DeMicco, David A.; Luo, Don; Betteridge, D. John; Colhoun, Helen M.; Durrington, Paul N.; Livingstone, Shona J.; Fuller, John H.; Hitman, Graham A. // Diabetes Care;Nov2006, Vol. 29 Issue 11, p2378 

    OBJECTIVE -- Rates of cardiovascular disease are highest in the elderly. Lipid-lowering statin therapy reduces the proportional risk as effectively in older patients as in younger individuals; however, limited data are available for elderly patients with type 2 diabetes. We conducted a post hoc...

  • EFFICACY OF STATINS AND FIBRATES IN ALTERING THE LIPID PROFILE IN HYPERTENSIVE PATIENTS. SHAH, MADIHA; WAGAN, MAHBOOB AHMED; SHAH, SHAHEEN; BHURGRI, ALI NAWAZ // Medical Channel;Jul-Sep2012, Vol. 18 Issue 3, p74 

    Lipid lowering drugs have become most powerful Pharmacological strategies in treatment of cardiovascular diseases. In our study of 100 patients having an age range from 35 to 65 years were enrolled. The antihypertensive used were Angiotensin Converting Enzym Inhibitors (Lisinopril 10mg / day) &...

  • Appropriateness of clopidogrel use according to current recommendations. Fornós-Garrigós, Antonio; Orozco-Beltrán, Domingo; Gil-Guillén, Vicente F; Puig-Barberà, Joan; Fluixa, Carlos; Fernández, Antonio // Family Practice;Dec2014, Vol. 31 Issue 6, p694 

    Background. Clopidogrel is widely used in cardiovascular prevention. However, the prescription of clopidogrel in clinical practice does not match the recommendations concerning its indication and treatment duration. Objective. To assess the appropriateness of clopidogrel prescription according...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics